Funding for this research was provided by:
National Science Foundation of China (31800814)
National Key Research and Development Program of China (2017YFC0110401)
Article Title: Construction of Durvalumab/carbon nanotube/PEI/aptamer-siRNA chimera for the immunotherapy of hepatocellular carcinoma
Journal Title: Biomedical Materials
Article Type: paper
Copyright Information: © 2022 The Author(s). Published by IOP Publishing Ltd
Publication dates
Date Received: 2021-10-08
Date Accepted: 2022-02-10
Online publication date: 2022-02-22